Aliquots Archives
Evolution of a deadly virus
May. 23, 2018—Genomic sequences have revealed that Florida is a major source of a mosquito-borne virus that causes disease in horses and humans.
New target to stop Ebola
May. 21, 2018—A new Vanderbilt study suggests it may be possible to develop antibody therapies or a universal vaccine effective against multiple Ebola virus family members.
Shaping reward circuits
May. 18, 2018—Using techniques to control and monitor the activities of individual neurons, Vanderbilt investigators are probing the brain’s reward circuitry.
Alphavirus “Achilles heel”
May. 17, 2018—Targeting the protein that mosquito-borne viruses use to enter cells could be a strategy for preventing infection by multiple emerging viruses.
Putting the brakes on sepsis
May. 9, 2018—An enzyme called PTEN reduces inflammatory signaling and mortality in sepsis, suggesting it may be a good therapeutic target for this life-threatening complication of infection.
Records point to drug-drug interaction
May. 7, 2018—Patients who take a cholesterol-lowering statin drug while taking the antibiotic daptomycin have increased risk of developing muscle weakness or a more severe form of muscle damage.
New breast cancer targets
May. 4, 2018—A special genetic analysis has revealed candidate genes associated with increased risk of breast cancer.
Understanding HDL structure
May. 3, 2018—Structural features of newly formed HDL particles will help guide understanding of “good cholesterol” and its function.
Toxin floats on lipid rafts
Apr. 23, 2018—The bacterium H. pylori is a leading cause of stomach cancer, and Vanderbilt researchers are studying how one of its toxins gets into cells.
Disease-fighting antibody production
Apr. 20, 2018—New research links nutrient-responsive cellular signaling to the antibody-mediated immune response.
How the skin protects
Apr. 19, 2018—Treatments for common skin conditions such as atopic dermatitis may be improved by understanding the enzymes responsible for forming the skin’s water-tight barrier.
“Idling” cancer cells may return
Apr. 11, 2018—Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment.
